5//SEC Filing
Pearson Mark E. 5
Accession 0001683168-24-002047
CIK 0001563577other
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 9:36 PM ET
Size
15.8 KB
Accession
0001683168-24-002047
Insider Transaction Report
Form 5
Transactions
- Sale
Common Stock
2024-01-11$0.23/sh−400,000$90,240→ 4,880,000 total(indirect: See fn.) - Sale
Common Stock
2024-03-22$0.23/sh−20,000$4,600→ 4,860,000 total(indirect: See fn.) - Sale
Common Stock
2024-03-25$0.22/sh−780,000$170,742→ 4,080,000 total(indirect: See fn.) - Sale
Common Stock
2024-03-26$0.20/sh−2,000,000$393,000→ 2,080,000 total(indirect: See fn.) - Sale
Common Stock
2024-03-27$0.17/sh−306,924$52,146→ 1,773,076 total(indirect: See fn.) - Sale
Common Stock
2024-03-28$0.15/sh−693,076$101,120→ 1,080,000 total(indirect: See fn.)
Pearson Mark E.
10% Owner
Transactions
- Sale
Common Stock
2024-01-11$0.23/sh−400,000$90,240→ 4,880,000 total(indirect: See fn.) - Sale
Common Stock
2024-03-25$0.22/sh−780,000$170,742→ 4,080,000 total(indirect: See fn.) - Sale
Common Stock
2024-03-26$0.20/sh−2,000,000$393,000→ 2,080,000 total(indirect: See fn.) - Sale
Common Stock
2024-03-22$0.23/sh−20,000$4,600→ 4,860,000 total(indirect: See fn.) - Sale
Common Stock
2024-03-27$0.17/sh−306,924$52,146→ 1,773,076 total(indirect: See fn.) - Sale
Common Stock
2024-03-28$0.15/sh−693,076$101,120→ 1,080,000 total(indirect: See fn.)
Footnotes (1)
- [F1]Mark Pearson is the Manager and sole Member of Altamont Pharmaceutical Holdings LLC ("Altamont"). Altamont owns 5,280,000 shares of Galera Therapeutics, Inc. Mark Pearson does not personally own any shares. As the Manager and sole Member of Altamont, Mark Pearson possesses the power to vote and dispose of or direct the disposition of 5,280,000 shares.
Documents
Issuer
Galera Therapeutics, Inc.
CIK 0001563577
Entity typeother
Related Parties
1- filerCIK 0001486558
Filing Metadata
- Form type
- 5
- Filed
- Mar 31, 8:00 PM ET
- Accepted
- Apr 1, 9:36 PM ET
- Size
- 15.8 KB